mesalamine has been researched along with Abscess, Abdominal in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"Separate risk prediction models for Crohn's disease-related surgery and complications were developed using clinical trial data involving community gastroenterology practices." | 1.48 | Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease. ( Dulai, PS; Feagan, BG; Guizzetti, L; Jairath, V; Khanna, R; Sandborn, WJ; Zou, G, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guizzetti, L | 1 |
Zou, G | 1 |
Khanna, R | 1 |
Dulai, PS | 1 |
Sandborn, WJ | 1 |
Jairath, V | 1 |
Feagan, BG | 1 |
1 other study available for mesalamine and Abscess, Abdominal
Article | Year |
---|---|
Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.
Topics: Abdominal Abscess; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroi | 2018 |